EBD Group is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Principal at Southern Cross Biotech Consulting LLC
She is former President and CEO at FORUM Pharmaceuticals a company focused in Alzheimer’s disease and in Schizophrenia. She served as president and CEO of Millennium Pharmaceuticals from 2005 to 2013, during which time Takeda Pharmaceuticals of Japan acquired the company for $8.8 billion to build an oncology franchise. Following the acquisition, Deborah became the first woman to be appointed to the Japanese governing board of Takeda Pharmaceuticals. Prior to her role at Millennium, Deborah spent 17 years at Sandoz and Novartis and led the Novartis Oncology business in North America, launching a number of transformational cancer therapies. Deborah was born in Zimbabwe and completed her medical training at the University of the Witwatersrand in South Africa.